Advertisement
GLAS vs TLRY
Which Stock Would AI Choose? Glass House Brands (GLAS) vs. Tilray Brands (TLRY) Stock Comparison
Key Takeaways
- GLAS is a vertically integrated California-focused cannabis producer, while TLRY is a diversified global cannabis and consumer packaged goods company.
- GLAS has reported record biomass production and falling production costs, while TLRY's top-line growth has been driven largely by its beverage segment as core cannabis sales have contracted.
- Both names have experienced sharp price declines; TLRY is down roughly 71% year to date, and GLAS has fallen well below its 52-week high despite operational progress.
- Tickeron AI Verdict: Based on trend consistency, cost leadership, and operational momentum, GLAS is the current ticker of choice in this two-stock comparison.
- For more context, explore GLAS Major News and GLAS Today's Price Move, as well as TLRY Major News and TLRY Today's Price Move.
- To see which automated strategies are currently favored, browse the Trending AI Robots section.
Introduction
Investors evaluating the cannabis sector often weigh a specialized, high-efficiency producer against a diversified, brand-led operator. This stock comparison examines Glass House Brands (GLAS), a vertically integrated cultivator concentrated in California, and Tilray Brands (TLRY), a global company spanning cannabis, beverages, and wellness products. Although both operate in the same broad industry, their business models, growth drivers, and risk profiles differ meaningfully. Traders focused on relative performance, market positioning, and operational momentum may find this comparison useful when assessing which name offers a more consistent setup in the current environment.
GLAS Overview and Recent Performance
Glass House Brands is one of the largest greenhouse cannabis cultivators in the California market, operating under brands such as Glass House Farms, PLUS Products, Allswell, and Mama Sue Wellness. The company's strategy centers on low-cost biomass production, and it has been pursuing GACP (Good Agricultural and Collection Practice) certifications to build a pathway toward international export.
In recent weeks, GLAS reported preliminary third-quarter results showing record biomass production of approximately 317,000 pounds and a further reduction in cost of production to roughly $110 per pound. Management reaffirmed its full-year production guidance near one million pounds and its longer-term cost target of $95 per pound. However, average selling prices declined from the prior quarter, compressing gross margin even as revenue grew sharply year over year. The company also raised capital through an ATM (At-The-Market) offering and has since stated it paused that program. Sentiment has been mixed: analyst price targets were trimmed while ratings remained broadly constructive, and the share price has pulled back notably from its 52-week high.
TLRY Overview and Recent Performance
Tilray Brands is a global lifestyle and consumer packaged goods company with operations spanning cannabis, craft beverages, and wellness products across North America, Europe, and other regions. Its portfolio includes cannabis brands, the BrewDog beer business, and a range of craft beverage assets, giving it exposure beyond cannabis cultivation alone.
In recent market activity, TLRY reported record quarterly revenue of roughly $257 million, up about 23% year over year, with gross margin improving to around 30%. Much of that growth has come from the beverage segment and international markets, while core cannabis sales declined by double digits. The company announced a Canadian cultivation consolidation expected to generate about $10 million in annualized cost savings, alongside a U.S. brewing consolidation targeting roughly $20 million in savings, and it raised the lower end of its adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) guidance. Despite these efficiency efforts, the stock remains well below its 52-week high, and profitability has continued to weigh on investor sentiment.
Trending AI Robots
Tickeron operates a marketplace of hundreds of AI-powered trading bots that analyze thousands of different tickers across the market. Each bot follows its own trading style, strategy, timeframe, performance history, and watchlist of securities, so no two are alike. Rather than surfacing every available strategy, Tickeron curates a focused Trending AI Robots page that highlights only the bots best suited to current market conditions. This selection process is designed to help traders and investors identify automated approaches that align with prevailing momentum, volatility, and sector rotation. If you are interested in exploring data-driven strategies beyond this two-stock comparison, the Trending AI Robots page offers a practical starting point for reviewing bots that match your own timeframe and risk preferences.
Head-to-Head Comparison
The two companies represent contrasting approaches to the cannabis opportunity. GLAS is a production-driven, single-market operator competing on scale and cost efficiency, which makes its results highly sensitive to California wholesale pricing. TLRY is a diversified operator whose beverage and international businesses provide revenue breadth, but whose core cannabis segment has been contracting and whose overall profitability remains negative.
In terms of momentum, GLAS has shown a more consistent operational trajectory—rising output and falling unit costs—even as selling prices compressed. TLRY's growth narrative is more dependent on acquisitions and cost-cutting initiatives, with analysts offering a wide range of views on the stock. Risk factors also diverge: GLAS carries concentration risk tied to one state's regulatory and pricing environment, while TLRY carries integration risk from a broad, multi-brand portfolio and ongoing cash-burn concerns. Sector exposure is another key difference, with GLAS essentially a pure-play cannabis cultivator and TLRY a hybrid cannabis-beverage conglomerate.
Tickeron AI Verdict
Based on observable factors such as trend consistency, operational stability, and relative positioning, Tickeron's AI framework would likely favor GLAS over TLRY in the current environment. GLAS's record production volumes, sequential cost reductions, and clear path toward a low-cost leadership position suggest a more coherent operational trend than TLRY's acquisition-led growth offset by declining core cannabis sales. That said, both companies face meaningful headwinds, including pricing pressure and negative or near-breakeven cash generation. The verdict is therefore probabilistic rather than definitive, reflecting the balance of recent data rather than a guarantee of future performance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLAS is a Hold and TLRY is a Hold.
GLAS sees its Stochastic Oscillator climbs out of oversold territory
On November 02, 2026, the Stochastic Oscillator for GLAS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 50 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for GLAS just turned positive on October 28, 2026. Looking at past instances where GLAS's MACD turned positive, the stock continued to rise in 30 of 36 cases over the following month. The odds of a continued upward trend are 83%.
GLAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLAS as a result. In 66 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for GLAS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.699) is normal, around the industry mean (7.271). P/E Ratio (-2.737) is within average values for comparable stocks, (0.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (3.880) is also within normal values, averaging (181.047).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. GLAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
TLRY's Stochastic Oscillator drives into overbought zone
The Stochastic Oscillator for TLRY moved into overbought territory on November 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TLRY entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TLRY's RSI Indicator exited the oversold zone, 39 of 49 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TLRY as a result. In 63 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for TLRY just turned positive on November 04, 2026. Looking at past instances where TLRY's MACD turned positive, the stock continued to rise in 32 of 41 cases over the following month. The odds of a continued upward trend are 78%.
Following a +16.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in 166 of 210 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.254) is normal, around the industry mean (7.271). P/E Ratio (-2.679) is within average values for comparable stocks, (0.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (0.481) is also within normal values, averaging (181.047).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
GLAS | TLRY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 40 Fair valued | 22 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 93 | |
PRICE GROWTH RATING 1..100 | 96 | 85 | |
P/E GROWTH RATING 1..100 | 6 | 15 | |
SEASONALITY SCORE 1..100 | 85 | 3 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TLRY's Valuation (22) in the Biotechnology industry is in the same range as GLAS (40) in the null industry. This means that TLRY’s stock grew similarly to GLAS’s over the last 12 months.
TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GLAS (100) in the null industry. This means that TLRY’s stock grew similarly to GLAS’s over the last 12 months.
TLRY's SMR Rating (93) in the Biotechnology industry is in the same range as GLAS (98) in the null industry. This means that TLRY’s stock grew similarly to GLAS’s over the last 12 months.
TLRY's Price Growth Rating (85) in the Biotechnology industry is in the same range as GLAS (96) in the null industry. This means that TLRY’s stock grew similarly to GLAS’s over the last 12 months.
GLAS's P/E Growth Rating (6) in the null industry is in the same range as TLRY (15) in the Biotechnology industry. This means that GLAS’s stock grew similarly to TLRY’s over the last 12 months.
| GLAS | TLRY | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 79% | 4 days ago 80% |
| Stochastic ODDS (%) | 4 days ago 83% | 4 days ago 90% |
| Momentum ODDS (%) | 4 days ago 80% | 4 days ago 80% |
| MACD ODDS (%) | 4 days ago 83% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 88% | 4 days ago 80% |
| TrendMonth ODDS (%) | 4 days ago 89% | 4 days ago 89% |
| Advances ODDS (%) | N/A | 6 days ago 79% |
| Declines ODDS (%) | 4 days ago 88% | 11 days ago 90% |
| BollingerBands ODDS (%) | 4 days ago 70% | N/A |
| Aroon ODDS (%) | 4 days ago 87% | 4 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GLAS’s FA Score shows that 1 FA rating(s) are green while TLRY’s FA Score has 2 green FA rating(s).
- GLAS’s FA Score: 1 green, 4 red.
- TLRY’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GLAS’s TA Score shows that 4 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).
- GLAS’s TA Score: 4 bullish, 3 bearish.
- TLRY’s TA Score: 4 bullish, 3 bearish.
Price Growth
GLAS (@Pharmaceuticals: Generic) experienced а -4.59% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was +15.42% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.13%. For the same industry, the average monthly price growth was -8.24%, and the average quarterly price growth was +8.66%.
Reported Earning Dates
GLAS is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (+2.13% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
GLAS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GLAS has been loosely correlated with TRLV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GLAS jumps, then TRLV could also see price increases.
| Ticker / NAME | Correlation To GLAS | 1D Price Change % | ||
|---|---|---|---|---|
| GLAS | 100% | -6.73% | ||
| TRLV - GLAS | 64% Loosely correlated | +6.06% | ||
| CGC - GLAS | 63% Loosely correlated | -3.58% | ||
| TLRY - GLAS | 53% Loosely correlated | +3.91% | ||
| ACB - GLAS | 50% Loosely correlated | +0.96% | ||
| OGI - GLAS | 47% Loosely correlated | -5.72% | ||
More | ||||
TLRY and
Correlation & Price change
A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.
| Ticker / NAME | Correlation To TLRY | 1D Price Change % | ||
|---|---|---|---|---|
| TLRY | 100% | +3.91% | ||
| SNDL - TLRY | 76% Closely correlated | +2.54% | ||
| CGC - TLRY | 75% Closely correlated | -3.58% | ||
| ACB - TLRY | 65% Loosely correlated | +0.96% | ||
| CRON - TLRY | 64% Loosely correlated | -2.96% | ||
| GLAS - TLRY | 59% Loosely correlated | -6.73% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| POEL | 2.93 | 0.85 | +40.87% |
| Defiance Daily Target 2X Long POET ETF | |||
| QTEC | 268.15 | 3.43 | +1.30% |
| First Trust NASDAQ-100 Technology Sector Index Fund (QTEC) | |||
| NBOS | 27.75 | 0.02 | +0.08% |
| Neuberger Option Strategy ETF (NBOS) | |||
| SWAN | 31.82 | 0.02 | +0.07% |
| Amplify BlackSwan Growth & Treasury Core ETF (SWAN) | |||
| CPRJ | 27.36 | N/A | +0.02% |
| Calamos Russell 2000 Structured Alt Protection ETF July (CPRJ) | |||